Skip to main content
Leland Metheny III, MD, Hematology, Cleveland, OH, University Hospitals Cleveland Medical Center

LelandLMethenyIIIMD

Hematology • Cleveland, OH

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Metheny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Metheny's full profile

Already have an account?

  • Office

    UH Cleveland Medical Center
    11100 Euclid Ave Department of Medicine-Hematology and Oncology
    Cleveland, OH 44106
    Phone+1 216-844-3951
    Fax+1 216-844-5759
  • Is this information wrong?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2008 - 2012
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2008
  • Case Western Reserve University
    Case Western Reserve UniversityB.A., English, with Honors, 2000 - 2004
  • Case Western Reserve University
    Case Western Reserve UniversityB.S., Biology, 2000 - 2004

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2015 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • K12 Scholar, Paul Calabresi Career Development Award University Hospitals Cleveland Medical Center, 2015
  • Fellow Research Award, Department of Medicine Case Western Reserve University, 2014
  • Summer Program in Undergraduate Research Award Recipient 2002
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 12017  
    Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hagelstrom RT, Hobbs G, Jagasia M, Kantarjian HM, Kropf P, Metheny L, Moore JO..., J Natl Compr Canc Netw, 1/1/2016
  • Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells  
    Metheny L, Eid S, Lingas K, Reese J, Meyerson H, Tong A, de Lima M, Huang AY, Hematol Med Oncol, 1/1/2016
  • Human mesenchymal stem cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation  
    Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cook..., Stem Cells, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Umbilical Cord Blood Banking and Transplantation. 
    Chapter: Cord Blood ex vivo expansion. 
    Caimi PF, Metheny L, de Lima MEditors: Karen Ballen.Humana Press/ Springer, New York, NY2014

Abstracts/Posters

  • Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction
    Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay
    Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas
    Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Impact of Maintenance Therapy on Nature of First Relapse in Multiple Myeloma Patients Underwent Autologous Stem Cell Transplant 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • University Hospitals First in Ohio to Treat Patients with Two FDA Approved CAR T Cancer Therapies
    University Hospitals First in Ohio to Treat Patients with Two FDA Approved CAR T Cancer TherapiesMay 6th, 2021
  • Significant Costs and Low Utilization of Stored Peripheral Blood Stem Cells for Salvage Autologous Transplant in Multiple Myeloma Patients Including Those Meeting mSMART Criteria
    Significant Costs and Low Utilization of Stored Peripheral Blood Stem Cells for Salvage Autologous Transplant in Multiple Myeloma Patients Including Those Meeting mSMART CriteriaJanuary 29th, 2021
  • New Trials Following Successful Approach to Producing and Using Anti-CD19 CAR T Cells Against B-cell Malignancies
    New Trials Following Successful Approach to Producing and Using Anti-CD19 CAR T Cells Against B-cell MalignanciesDecember 21st, 2021

Hospital Affiliations

Dr. Leland Metheny, Dr. Leland Metheny, MD, Dr. L Metheny, Dr. Leland L Metheny